Ohio’s Third Frontier Project aims to establish a high-tech, knowledge economy in the state by supporting leading-edge research and development. As part of this project, the Biomedical Research Commercialization Program (BRCP) (formerly called the Biomedical Research and Partnership) funds innovative projects with commercial potential in biomedicine and biotechnology. The BRCP has funded several Medical Center programs, including:
- a $6.5 million cardiovascular bioengineering enterprise
- a $1.49 million study on the genetics of gastrointestinal cancer led by Albert de la Chapelle, MD, PhD, and subcontracted from Case Western Reserve University
- a $6 million biomedical informatics synthesis platform led by Joel Saltz, MD, PhD
- a $17.1 million biomedical structural, functional and molecular imaging enterprise led by Michael Knopp, MD, PhD
- a $7.9 million biomedical structural, functional and molecular imaging enterprise (part 2) led by Michael Knopp, MD, PhD
- an $8 million comprehensive program for the prevention, detection and treatment of lung cancer led by Michael Caligiuri, MD
- a $4.25 million commercialization platform for immunotherapeutic treatment of multiple sclerosis led by Caroline Whitacre, PhD
- a $556,834 stem cell and tissue engineering institute led by Larry Lasky, MD